Profitelligence Profitelligence · Filing Ledger Open TWST research →

Form 8-K · Current Report · Filed 2026-02-06

Twist Bioscience Shareholders Approve Key Proposals

At the 2026 Annual Meeting, Twist Bioscience Corporation shareholders approved the election of three new directors to the Board, affirmed the compensation of the Named Executive Officers on an advisory basis, and ratified the appointment of Ernst & Young LLP as the independent registered accounting firm for fiscal year 2026.

Filer
Twist Bioscience Corporation TWST · NASDAQ
Filed
Accession
0001581280-26-000022
CIK
0001581280
Signal
Medium impactHealthcare

Items reported

Item events

Reported Item

Board Member Appointed General Statement Auditor Resignation

Market reaction

Close before filing

$47.10

Next session

+0.8%

Since filing

+230.3%

Latest close

$155.56

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TWST reporting the same item, with the next session's move:

Twist Bioscience Announces 17% Revenue Growth and Raises Guidance+12.8%
Twist Bioscience Reports 17% Revenue Growth for Q1 Fiscal 2026+13.9%

About Twist Bioscience Corporation

Twist Bioscience Corporation is a synthetic biology and biotechnology company that develops and commercializes DNA-based products built on its proprietary silicon-based synthesis platform. Twist Bioscience Corporation’s core offerings include synthetic genes, DNA oligos, oligo pools, library preparation tools, antibody libraries, and other workflow products used in next-generation sequencing, gene editing, drug discovery, diagnostics, and research. The company serves customers across academic, pharmaceutical, biotech, industrial, and agricultural markets, providing scalable tools for applications that require precise, high-quality synthetic DNA. Its platform supports high-throughput manufacturing and a broad product portfolio that helps researchers and developers design, test, and advance biological innovation across multiple life science segments. Headquartered in South San Francisco, California, Twist Bioscience Corporation plays a specialized role in the global market for synthetic DNA and genomics-enabled research tools.

Exchange NASDAQ Industry Diagnostics & Research Company website ↗

Never miss another TWST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts